CYP19A1 and endometrial cancer: In this review, we aim to summarize the most relevant literature for hormonal therapy in endometrial cancer, including single-agent and combinations of progesterones, selective estrogen receptor modulators and degraders, aromatase inhibitors, as well as hormonal combinations with other targeted therapies.